Health Care Lawyers Leave Firms for Companies Above the Market Rate

A company that sets out to hire in-house healthcare counsel recruits from a practice whose lawyers already lean toward companies. Sartori & Partners data show that health care lawyers made 44 moves from law firms to companies between May and October 2026, or 18.4 for every hundred lateral moves in the practice over the same six months. Across all practices the figure was 13.1. The catch is that firms want the same people: health care lateral hiring rose 14.5% year on year. This report sets the in-house rate against the market, then measures the firm demand, the health industry deal work behind it, the level mix of the bench and the cities a health company would recruit from.

Moves from firms to companies are tracked in full only from May 2026, so the rate covers six months and has no earlier year to set against it. In that window, 44 health care lawyers left a law firm for a company, while 239 moved laterally to another firm. That gives 18.4 moves to companies for every hundred lateral moves, 1.4 times the market rate. Across every practice, 953 lawyers went to companies against 7,281 lateral moves, for a rate of 13.1.

Shares tell the same story. Health care was involved in 4.6% of all moves from firms to companies over the six months, against 3.0% of lateral moves over 12 months. One move can carry several practices, so both figures are shares of moves involving health care, not slices of a whole. For a health company, the point is practical: the lawyers it approaches are more open than the average firm lawyer to a corporate seat, so a search rarely fails for lack of interest. It fails on competition, which the next section measures.

In the Sartori & Partners lateral database, 434 health care lawyers changed firms in the 12 months to September 2026, against 379 a year before, so hiring in the practice rose 14.5%. Over the same windows the whole lateral market rose 9.0%, from 13,128 moves to 14,305. Partner hiring moved less: 160 health care partners changed firms against 150, and the partner count held flat (+6.7%). The extra demand sits mainly below partner level, which is where companies hire too.

The demand is also concentrated. The ten firms that hired most took 25.0% of individual health care hires over 12 months, against 12.9% for the top 10 across all practices, and 205 firms hired at least one health care lawyer. A company making an offer to a health care associate or counsel should assume that one of the firms below is in the same conversation, and should leave room in the timetable for a counter-offer.

Firm hiring follows the work, and the work grew. Deals involving pharma and biotech rose 14.5% year on year, from 2,880 to 3,298 in the settled 12-month windows. Deals for healthcare providers and payors rose 13.4%, from 956 to 1,084. Medical device deals held flat (+6.9%), at 810 against 758, the one health industry without a clear rise.

The lawyers who list these industries as their own focus did not change firms any faster. Lateral moves by lawyers focused on pharma and biotech held flat (+2.1%), and moves by those focused on providers and payors held flat (+0.0%). Device specialists who moved were mostly partners, at 63.3% of their moves, against 36.3% in the health care practice. More deals and a steady number of specialists on the move mean the industry experts a company wants are busy where they sit. Their firms have every reason to keep them, so a company should budget for a longer approach.

Most lawyers who go in-house are associates: across all practices they made 76.7% of moves from firms to companies. Health care lateral moves lean the other way. Associates made 50.1% of them over 12 months, against 58.5% in the whole market, while partners made 36.3% against 27.7%.

The associate share sits 8.4 points below the market, at exactly the level that companies hire most. Health care lawyers also relocate less: 17.3% of their lateral moves with both cities known involved a change of city, against 20.5% market-wide. A company that needs a mid-level health lawyer should widen the search to counsel, who made 11.5% of health care moves, and should expect to hire where the candidate already lives rather than move them.

Washington, DC took 12.6% of health care lateral moves over 12 months, an index of 225 on a scale where the market's own share is a hundred. New York, the largest lateral market overall, took 7.6%, an index of 51. Chicago sat above the market at 118.

The industry focus lists sharpen the map. Among lawyers focused on pharma and biotech who changed firms, Boston took 18.6%, an index of 718. Among device specialists, Washington, DC took 15.6%, an index of 278. A health company recruiting regulatory counsel should start in Washington; a pharma or biotech company should add Boston; a search confined to New York reaches a smaller health bench than the city's size suggests.

Three findings shape a health care search. First, interest is not the constraint: health care lawyers joined companies at 18.4 for every hundred lateral moves, above the market's 13.1, so a well-defined role will draw candidates. Second, firms are bidding for the same people. Health care lateral hiring rose 14.5%, provider and payor deals rose 13.4%, and the ten most active firms took 25.0% of hires, so expect counter-offers and set the compensation range before the first interview, not after. Third, the associate pool is thinner than elsewhere, at 50.1% of moves, so open mid-level roles to counsel and to candidates in Washington, DC and Boston. Sartori & Partners tracks these moves from public law-firm announcements, firm websites and professional profiles, checked monthly.